Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 701-707

  Gascon I ^a   Pascual, S ^a   Plazas, J ^a   Sanchez J ^a   Frances R ^a   Mas P ^a   Zapater, P ^a   Perez Mateo M ^a   Such, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; DRUG RESISTANCE; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTIOUS COMPLICATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROPHYLAXIS; STRAIN DIFFERENCE;

ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; INHIBITORY CONCENTRATION 50; LIVER CIRRHOSIS; MOUTH MUCOSA; NORFLOXACIN; QUINOLONES;

EID: 16344381933     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02366.x     Document Type: Article

References (38)

1. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman, M. Scharschmidt, B. Sleisenger, M. eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Pathophysiology/diagnosis/treatment. Philadelphia, USA: WB Saunders. 1998: 1310-33.
2. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
3. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
4. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372-8.
5. Such J, Guarner C, Runyon BA. Spontaneous bacterial peritonitis. In: Arroyo, V. Gines, P. Rodes, J. Schrier, RW. eds. Ascites and Renal Dysfunction in Liver Disease. Maiden, MA, USA: Blackwell Science. Inc., 1999: 99-115.
6. Such J, Frances R, Munoz C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, non-neutrocytic ascites. Hepatology 2002; 36: 135-41.
7. Frances R, Benlloch S, Zapater P, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004; 39: 484-91.
8. Llovet JM, Bartoli R, Planas R, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996; 23: 781-7.
9. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-72.
10. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12 (4 Pt 1): 716-24.
11. Such J, Guarner C, Soriano G, et ed. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 1990; 12: 1175-8.
12. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003; 38: 193-200.
13. Aparicio JR, Such J, Pascual S, et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999; 31: 277-83.
14. Dupeyron C, Mangeney N, Sedrati L, et al. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994; 38: 340-4.
15. Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol 1997; 26: 88-95.
16. Ortiz J, Vila MC, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999; 29: 1064-9.
17. Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995; 21: 674-9.
18. Abalia I, Rodriguez E, Umaran A, et al. Modulation of P-fimbriation by ciprofloxacin in uropathogenic Escherichia coli. Enferm Infecc Microbiol Clin 1997; 15: 255-9.
19. Breines DM, Burnham JC. The effects of quinolones on the adherence of type-1 fimbriated Escherichia coli to mannosylated agarose beads. J Antimicrob Chemother 1995; 36: 911-25.
20. Ofek I, Beachey EH, Eisenstein BI, Alkan ML, Sharon N. Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis 1979; 1: 832-7.
21. Sonstein SA, Burnham JC. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. Diagn Microbiol Infect Dis 1993; 16: 277-89.
22. Vranes J, Zagar Z, Kurbel S. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated Escherichia coli. J Chemother 1996; 8: 254-60.
23. Vranes J. Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. Chemotherapy 1996; 42: 177-85.
24. Baquero F, Martinez-Beltran J, Canton R. Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics. Enferm Infecc Microbiol Clin 1998; 16: 85-92.
25. Malouin F, Chamberland S, Brochu N, Parr TR Jr. Influence of growth media on Escherichia coli cell composition and ceftazidime susceptibility. Antimicrob Agents Chemother 1991; 35: 477-83.
26. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669-74.
27. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992; 23: 217-44.
28. Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 2000; 16: 5-15.
29. Kidwai M, Misra P, Kumar R. The fluorinated quinolones. Curr Pharm Des 1998; 4: 101-18.
30. Runyon BA, Borzio M, Young S, et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995; 21: 1719-24.
31. Soriano G, Guarner C, Teixido M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991; 100: 477-81.
32. Novella M, Sola R, Soriano G, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997; 25: 532-6.
33. Connell H, Hedlund M, Agace W, Svanborg C. Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Adv Dent Res 1997; 11: 50-8.
34. Mannhardt W, Becker A, Putzer M, et al. Host defense within the urinary tract: I. Bacterial adhesion initiates an uroepithelial defense mechanism. Pediatr Nephrol 1996; 10: 568-72.
35. Smith H. Virulence determinants of Escherichia coli present knowledge and questions. Can J Microbiol 1992; 38: 747-52.
36. Velasco M, Horcajada JP, Mensa J, et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001; 33: 1682-6.
37. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17: 203-17.
38. Soriano G, Guarner C, Tomas A, et al. The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients. Rev Esp Enferm Dig 1992; 81: 322-6.